Phacilitate's annual cell and gene therapy manufacturing capacities review reaches North America. Brought to you in partnership with Aldevron.
As the cell and gene therapy industry grows manufacturing capacity and capabilities will be crucial for both clinical and commercial success. If the capacity limitations aren't rectified costs will continue to rise putting the long-term success and accessibility of advanced therapies at risk.
Some say, controlling your manufacturing is controlling your fate. It's, therefore, crucial to ensure you have access to enough capacity and expertise in enough time.
This interactive map provides information about where and when manufacturing capacity is available across North America, along with detail about the facilities and clean rooms. You will also find in-depth information about Aldevron's new facility in Fargo, North Dakota.